ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

NITISINONUM

Active substance (INN) · ATC A16AX04 · 3 products authorised in Romania

◀ Back

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

Code	Protocol	Status	Role	Sublist	GP
A16AX04	NITISINONUM	In force	medicine of the protocol	C1-G22	NO

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand name	Form	Strength	Holder	ATC	Rx
ORFADIN 10mg	CAPS.	10mg	SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB - SUEDIA	A16AX04	P-RF/R
ORFADIN 2mg	CAPS.	2mg	SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB - SUEDIA	A16AX04	P-RF/R
ORFADIN 5mg	CAPS.	5mg	SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB - SUEDIA	A16AX04	P-RF/R

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.